drugset / Trial / NCT03877562

The Effect of CORT118335 on Olanzapine-Induced Weight Gain

NCT03877562

Phase 1 Completed 96 enrolled Corcept Therapeutics
RandomizedParallel-groupDouble-blindPrevention

Summary

This study will investigate if there is any difference in the amount of weight gained by participants taking olanzapine with CORT118335 compared with olanzapine with placebo (a dummy test medicine which looks like CORT118335 but contains no active medicine). Safety and tolerability of CORT118335 when taken with olanzapine will also be evaluated.

Timeline

Start
2019-04-01
Primary completion
2020-03-13
Completion
2020-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Miricorilant Small molecule 600 mg Oral
Background Olanzapine Small molecule 10 mg Oral